How Do You Spell IDARUBICIN?

1. Idarubicin is a potent antineoplastic drug classified as an anthracycline antibiotic. It is derived from daunorubicin and belongs to the anthracycline group of chemotherapeutic agents. Idarubicin is primarily used in the treatment of various forms of cancer, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), as well as other types of solid tumors.

   This medication works by inhibiting the growth and replication of cancer cells by interfering with their DNA synthesis. Specifically, idarubicin binds to the DNA molecule, causing breaks in the DNA strands, inhibition of DNA topoisomerase II, and interference with DNA synthesis during the S-phase of the cell cycle. This mechanism of action prevents the cancer cells from dividing and multiplying, leading to their eventual death.

   Idarubicin is typically administered intravenously by a healthcare professional in a clinical setting due to its potential for side effects and its potential to cause tissue damage if extravasation occurs. It is essential to closely monitor patients receiving idarubicin for possible adverse reactions, including myelosuppression (a decrease in blood cell production), cardiotoxicity (impairment of heart function), and gastrointestinal toxicity.

   In summary, idarubicin is a powerful chemotherapeutic agent primarily used in the treatment of certain types of cancer. It works by interfering with cancer cell DNA synthesis, leading to their destruction.

Common Misspellings for IDARUBICIN